Fundraising FoxAlta Partners — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
USGI Medical develops endoluminal medical devices that enable surgical procedures without incisions, targeting healthcare providers and patients seeking less invasive treatment options.
HardwareHealthtechMedical DevicesSan Clemente, US
Tracy Maahs(Executive Officer)inScott Moonly(Executive Officer, Director)inJohn Cox(Executive Officer)in
BoardMike Chuisano(Director)George Abi-Chahine(Director)
Board seatGuy Nohra· per SEC Form D · $4M raise · filed Jun 2019
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical DevicesDurham, US
Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)
Co-investorsAisling CapitalAsset Management CompanyCanaan PartnersFrazier Life SciencesPappas CapitalSanderling Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.